PATENT CLAIM ANALYSIS

Application Number: 15764239
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "008300"]

Abstract:
Provided herein are methods and compositions for treating disease-states associated with presence of increased number of ErbB4+ pro-inflammatory macrophages in a subject in need thereof. The methods include providing an activator of ErbB4 and administering a therapeutically effective amount of the activator to the subject. The compositions include an activator of ErbB4. In one embodiment, the activation of ErbB4 is Neuregulin-4.

Claim (Index 14):
The method of  claim 13 , wherein the reference value is the mean or median number of ErbB4 +  macrophages in a normal subject.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 90.0
- Lexical Diversity: 1.53488
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14236831', '14648207', '14743909', '11437988', '12972908']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7744524450019471
- 35 USC 102 Novelty (BERT): 0.5351621522691684
- Combined Prediction Score: 0.7505234157286692
- Mean Citation Score: 289.86239
- Max Citation Score: 359.80383
- Similarity Product: 200.1844071974444

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test